Helsinki:FARON

AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment

AGC Biologics will manufacture novel precision cancer immunotherapy treatment Clevegen SEATTLE, May 5, 2020 /PRNewswire/ -- AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has been selected to commercially manufacture the treatment Clevegen f...

2020-05-05 20:30 2639

Week's Top Stories